Cyient DLM shares crash 19% after Q2 miss, guidance; JPMorgan, Antique, MOFSL targets -
JPMorgan recommended 'Underweight' on the stock with a target price of Rs 530, implying a potential downside of 48 per cent. Kotak suggested 'Sell' and a target of Rs 790 on the stock.

Cyient DLM Ltd shares plunged 19 per cent in Friday's trade after its September quarter earnings and FY27 margin guidance missed Street estimates, triggering downgrades. The electronic manufacturing services (EMS) and design-led manufacturing (DLM) company lowered its FY27 Ebitda margin guidance to 9-10 per cent from 10-11 per cent earlier, with double-digit margins now expected from FY28. It expects revenue growth of over 30 per cent year-on-year (YoY) in H2FY27, with momentum continuing into FY28. Quarterly order intake is expected to remain above Rs 600 crore over the next two quarters.
Antique Stock Broking said revenue at Rs 393 crore was below its estimate of Rs 400 crore. Ebitda margin fell 135 basis points to 8.7 per cent, below its estimate of 10.4 per cent, due to investments in sales and product development.
"We cut FY27/28 EPS estimates by 10 per cent/2 per cent and downgrade the stock to 'HOLD' from 'BUY', revising our target to Rs 1,025 from Rs 1,031, based on an unchanged target multiple of 50x 1HFY29E EPS," Antique said.
JPMorgan recommended 'Underweight' on the stock with a target price of Rs 530, implying a potential downside of 48 per cent. Kotak Institutional Equities suggested 'Sell' and a target of Rs 790 on the stock.
Cyient DLM's fross margins for the quarter declined 380 bps YoY to 37.4 per cent on adverse revenue mix and product development purchases, analysts said. They said a record order book and a book-to-bill ratio of 1.6 times provide strong revenue visibility but continued investments in the sales organisation and expensed product development costs will keep FY27 margins in high single digits.
Motilal Oswal Financial Services (MOFSL) said Cyient DLM sustained strong growth in Q2, with a record order book of Rs 2,810 crore, reinforcing visibility for H2FY27 and beyond. It said the company was entering a multi-year growth phase, supported by continued momentum in aerospace, a rising contribution from box-build operations, a ramp-up in semiconductor equipment and four Electronic Products programmes expected to scale meaningfully from FY30.
"We estimate a CAGR of 30 per cent/41/63 per cent in revenue, Ebitda and adjusted PAT over FY26-29E. We reiterate our BUY rating on the stock with a target of Rs 1,320 (50x Sep’28 EPS, implying a 0.8x PEG ratio)," it said.
Related Stories

Muhurat Trading 2026: Samvat 2082 ends, Samvat 2083 begins - Sensex, Nifty end in red first time after 2017 | Reasons
Indian markets opened lower in Samvat 2083, with the Sensex and Nifty posting their first negative Muhurat Trading close since 2017. Rising oil prices, Middle East tensions, foreign investor outflows, a weaker rupee and higher US bond yields weighed on equities.

Nifty Outlook for November 9: Index eyes 25,500 after strongest weekly rally in five years
Looking ahead, the Nifty is expected to maintain a positive bias in the near term, supported by strong FII inflows, currency appreciation and resilient domestic fundamentals. However, following the sharp rally, some profit booking and intermittent consolidation cannot be ruled out.

ICICI Bank, Divi's among 14 NSE 500 stocks hit new highs in Muhurat session
Divi's Labs surged 6% to a new high of ₹10,950 in Diwali-special Muhurat trading session, after the pharma company reported 64% surge in Q2 net profit.
